Moderna Inc. (NASDAQ:MRNA) reported on Friday a second-quarter loss of $2.13 per share, beating the consensus of a $2.98 loss ...

All three can be given in one visit, usually at no cost under federal rules and private-insurance coverage. If you’re unsure ...

"We were both barely functional. I even wondered if we were having simultaneous heart failure," Debra DeAngelo told Newsweek.

(NASDAQ:MRNA) today reported financial results and provided business updates for the second quarter of 2025. "In the last three months, we advanced our pipeline with positive Phase 3 flu vaccine ...

Q2 2025 Earnings Conference Call July 31, 2025 8:30 AM ETCompany ParticipantsBrian Foard - Executive VP & Head of ...

A single dose of RSVPreF3 OA offered protection against RSV-related lower respiratory tract disease across three RSV seasons ...

In older adults, respiratory syncytial virus (RSV) is associated with an increased risk for cardiovascular outcome, especially heart failure events.

In older adults, respiratory syncytial virus (RSV) is associated with an increased risk for cardiovascular outcome, especially heart failure events.

The overall level of respiratory disease in the U.S. that includes COVID, flu, and RSV remains “very low.” Emergency room ...

Vaccines are the best way to protect yourself from those illnesses, as well as from viruses such as RSV, influenza, and COVID ...

Are you tired of hearing and thinking, let alone worrying about, COVID? I’ll bet you are. As much as we want to be done with ...